Polycystic Ovary Syndrome

Insulin-sensitizing drugs help thin and overweight patients with PCOS

Published in Women's Health Weekly, November 11th, 2004

Insulin-sensitizing drugs can help thin women with polycystic ovary syndrome (PCOS) even if they do not appear to be insulin resistant, broadening the range of women who can benefit from the therapy, researchers report.

"This is significant because up to 30% of women with polycystic ovary syndrome are not overweight, and it has not been clear if such women would benefit from treatment with an insulin sensitizing drug for improving fertility," said John E. Nestler, MD, chair of Virginia Commonwealth University's Division of Endocrinology and Metabolism, and lead author of the study in the October 2004 issue of the journal Fertility and Sterility.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-11-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry